Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jul 9.
Published in final edited form as: Early Interv Psychiatry. 2009 Aug;3(3):226–230. doi: 10.1111/j.1751-7893.2009.00137.x

Obstetric complications and risk for conversion to psychosis among individuals at high clinical risk

Vijay A Mittal a, Rachael Willhite a, Melita Daley b, Carrie E Bearden b, Tara Niendam c, Lauren M Ellman d, Tyrone D Cannon a,b
PMCID: PMC4090059  NIHMSID: NIHMS597690  PMID: 22640387

Abstract

Aim

Examining risk factors among high-risk populations stands to inform treatment and to elucidate our understanding of the pathophysiology of schizophrenia. Despite substantial evidence implicating the incidence of obstetric complications (OCs) as a risk factor for schizophrenia, little is known about the relationship between OCs and risk for conversion among high-risk individuals.

Methods

We prospectively followed individuals at high-risk for developing psychotic disorders for a 2-year period to determine if a history of OCs is associated with conversion.

Results

Individuals who converted to psychosis had significantly more OCs when compared to non-converting participants; a history of OCs was associated with increased odds of conversion (OR=4.90, CI:1.04/22.20). OCs were positively associated with prodromal symptomatology.

Conclusions

To date, this report represents the first empirical evidence suggesting that OCs confer increased risk of conversion to psychosis. It is possible that OCs interact with brain maturational processes in the pathophysiology of schizophrenia and can serve as a risk marker.

Keywords: Obstetric Complications, Prodromal, Conversion, Schizophrenia, Psychosis


Obstetric complications (OCs) are an integral component of a neural diathesis-stress model of schizophrenia, which posits that early brain lesions interacting with later neuroendocrine, neurodevelopmental and psychosocial factors result in the eventual presentation of clinical signs and symptoms of psychosis1,2. In support of this theory, several studies have observed that a history of OCs is associated with earlier onset and a poorer course of illness3,4. Although these investigations have provided evidence for OCs as a general putative marker, to date there has been little research aimed at determining if OCs confer a greater risk for conversion to psychotic disorders among clinical high-risk populations. Such ultra-high-risk (UHR) individuals exhibit a cluster of subthreshold psychotic symptoms, consistent with a prodromal syndrome, and have a roughly 35% rate of conversion to psychotic disorder over 2 years5.

If OCs are associated with conversion among UHR populations, this pattern would suggest a link between early neurodevelopmental insults and subsequent neuromaturational events thought to be related to the developmental pathogenesis of psychotic disorders during adolescence/early adulthood. Recent research suggests that early pharmacological and psychosocial interventions with UHR individuals can potentially improve the course of illness, or even prevent onset of psychosis6. Therefore, it has become priority to identify risk-markers that define those UHR individuals who are at the highest risk.

In the present study, high-risk individuals were assessed for a history of OCs and their diagnostic status was followed for a period of two-years. We hypothesized that a history of OCs would be associated with greater severity of symptomatology and a greater risk for conversion.

Method

Presentations describing the prodromal syndrome for psychosis were administered at local schools, hospitals, and community health care clinics and in addition, advertisements were placed on schizophrenia.com describing prodromal symptomatology in layperson terminology. Participants were evaluated through the Center for Assessment and Prevention of Prodromal States (CAPPS), a program at the University of California Los Angeles designed to identify and track individuals at genetic or behavioral risk for psychosis through the adolescent risk period (please see Meyer and colleagues (2005)7 for a detailed description recruitment and assessment procedures).

Participants underwent a screening assessment to determine the presence of a UHR syndrome (as assessed by the Structured Interview for Prodromal Syndromes; SIPS8); The SIPS8 defines a UHR syndrome by the recent onset of moderate to severe positive symptoms, and or a decline in global functioning accompanying the presence of schizotypal personality disorder. All individuals who met criteria were invited to participate in a longitudinal study. Assent and written consent were obtained from all participants and a guardian, in accordance with the guidelines of the university Human Subjects Review Committee and Institutional Review Board. Exclusion criteria included the diagnosis of Axis I schizophrenia-spectrum disorders, the presence of a neurological disorder, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of drug or alcohol abuse or dependence, and/or an intelligence quotient below 70.

To assess for the presence of Axis I disorders, the Structured Clinical Interview for Axis I DSM-IV Disorders (SCID)9 or the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)10 (for ages 14 and under) was administered during the Baseline, 6, months, 12-months, 2-year evaluations. Research has indicated that individuals identified as UHR using current criteria are at increased risk for developing schizophrenia as well as affective disorders with psychotic features6. These findings are consistent with genetic evidence of shared etiological factors among DSM psychotic disorders11,12. Consistent with this notion, the present study examines DSM Axis I psychosis, including both schizophrenia and affective disorder with psychotic features.

The occurrence of OCs was assessed during a parent interview, using the Lewis-Murray Obstetric Complications Scale13; the15 item retrospective inventory encompasses a broad range of complications including events during the antepartum period (e.g., rubella, rhesus incompatibility, pre-cpampsia), the intrapartum period (e.g., premature rupture of membranes, long/difficult labor, cord prolapsed, cesarean, breech or abnormal presentation, forceps/vacuum delivery), and postpartum (e.g, low birthweight, incubator/resuscitation, gross physical anomaly; it has been widely used and has shown good reliability and validity13. The total number of endorsed items was computed for each participant. Diagnostic and OC interviews were conducted by advanced psychology doctoral students (MA level) or licensed clinical psychologists; Intraclass Correlations (ICCs) ≥ 0.75 for all symptom ratings, k ≥ 0.80 for prodromal syndrome and DSM-IV diagnoses were met by each interviewer. Diagnostic examiners were kept blind to OC status and the purpose of the study throughout data collection.

Results

Forty-seven UHR individuals ranging in age from 12 to 35 years participated in the present study. Of these participants, 9 converted t o an Axis I psychotic disorder (19.15%) over the two-year follow-up. Pearson Chi-Square tests revealed no significant differences between Converted and Non-Converted groups in sex ratio [χ2(1)=.93, p=.33] or ethnicity [χ2(4)=7.13, p=.13], and a t-test indicated no group differences in age [t(45)=.30, p=.76]. Further, a series of t-tests indicated that there were no significant group differences in baseline positive [t(45)=.05, p=.95, (Converted: mean=2.53, SD=1.02; Non-Converted : mean=2.51. SD=.90)], negative [t(45)=-.55, p=.58, (Converted: mean=2.42, SD=1.21; Non-Converted mean=2.20, SD=1.02)], and total [t(45)=- .55, p=.58, (Converted: mean=2.32, SD=.89, Non-Converted: mean=2.15, SD=.70)] prodromal symptomatology. Thus, there were no significant between group differences in demographic or symptom variables at baseline. Table 1 provides a description of demographic characteristics and OC history for the sample and both groups.

Table 1. Demographic Characteristics and Obstetrical History of High-Risk Sample.

Non-Converted Prodromal Group(n = 38) Converted to Psychotic Disorder Group(n = 9) Total Sample(n = 47)
Age (yrs.)
M 16.39 16.06 6.32
(SD) (3.05) (2.15) (2.88)
Gender (%)
Males 60.5 77.8 63.8
Females 39.5 22.2 36.2
Ethnicity (%)
African American 7.9 22.2 10.6
Caucasian 65.7 33.4 59.6
Asian American - 11.1 2.1
Hispanic 13.2 22.2 14.9
Other 13.2 11.1 12.8
Obstetric complications(%)
Rubella/Syphilis/HIV - 11.1 2.1
Rhesus Incompatibility 2.6 - 2.1
Preeclampsia 2.6 - 2.1
Twin Birth Complicated - 11.1 2.1
Cord Prolapsed - 11.1 2.1
Premature Gestational Age - 11.1 2.1
Cesarean 13.2 33.3 17.0
Breech Presentation 2.6 11.1 4.3
High/Difficult Forceps 5.3 - 4.3
Low Birthweight - 22.2 4.3
Incubator/Resuscitation 2.6 33.3 8.5
Gross Physical Anomaly 2.6 - 2.1

Note: Percentages of OCs are based on items endorsed definite on the Lewis-Murray Obstetric Complications Scale; Items not endorsed by either group (antepartum hemorrhage, premature rupture of membranes, long/difficult labor) are omitted from the table.

An independent samples t-test showed significant differences in mean OC score between the Non-Converted (mean=1.60, SD=1.36) and the Converted group (mean=3.33, SD=2.73), indicating that UHR participants who converted to an Axis I psychotic disorder had a significantly more frequent number of OCs than those who did not convert [t(45)=- 2.75, p ≤ .01, eta squared=.14].

Odds ratios were computed to determine the extent to which a history of OCs contributed to increased risk for conversion. Among the Converted group, 6/9 patients experienced at least one definite OC whereas among the Non Converted group, 11/38 patients experienced a similar event. The analysis indicated that among prodromal participants, a history of at least one definite OCs is associated with an approximately 5 times greater likelihood of conversion (OR=4.90, CI:1.04/22.20).

Bivariate correlations were conducted to determine the relationship between number of OCs and baseline prepsychotic symptoms, as assessed by the SIPS8. There was a moderate positive relationship between OCs and total symptoms (r=.31, p≤.01) and a trend for a relationship between OCs and SIPS negative symptoms (r=.22, p=.06).

Discussion

Our finding that OCs are associated with conversion to psychosis among a UHR population suggests a link between early neurodevelopmental insults and later neuromaturational processes thought to be related to the developmental pathogenesis of psychotic disorders during adolescence/early adulthood. One possibility is that OCs resulting in fetal hypoxia may render the brain more vulnerable to later (post-pubertal) neurodevelopmental events, thus increasing the likelihood of conversion to psychosis3. This notion is consistent with evidence suggesting that temporal lobe regions vulnerable to hypoxia are also frequently implicated in the pathophysiology of schizophrenia,14,15. Furthermore, since fetal hypoxia also results in a reduction of cell density in the hippocampus, a region responsible for regulating the hypothalamic-pituitary-adrenal axis1, OCs may be indirectly responsible for the aberrant endocrine activity/stress-response characteristic of individuals with schizophrenia1,2,16.

Yun and colleagues17 examined the incidence of OCs among a high-risk sample (n=74) and reported that OCs did not appear to be a significant risk factor. However, the authors noted several limitations in the study may have contributed to null findings and that it was premature to dismiss OCs as a risk factor17. In support of this conclusion, Ballon et al.18 recently examined 52 clinical high-risk individuals, and compared the incidence of OCs with non-psychiatric and schizophrenia comparison groups; the authors found comparable and significant elevations in OCs in the clinical ultra high-risk and schizophrenia groups. The trend of present findings may differ from the noted study conducted by Yun and colleages17 because the period of investigation was extended (from 12 months to 24 months), and the criteria for conversion were more stringent (the definition of conversion was changed from an acute psychotic episode17 to formal DSM-IV criteria for an Axis I psychotic disorder).

It is important to note that OCs of the type coded for in this study occur in 15-20% of the general population, the majority of individuals who experience OCs do not develop psychosis, and a majority of individuals with schizophrenia have not had a detectable OC19. Thus, the present findings may apply to a minority of the population with psychotic disorders. A significant limitation is the reliance on parental report of OCs, as several studies have found that mothers of both schizophrenia and high-risk children show a tendency to over-report OCs20. However, it should be noted that the information on OC history was collected before the parents or investigators knew whether any individual would develop psychosis. Another limitation relates to potential sampling bias; the recruitment strategy focused upon help-seeking individuals and therefore may not be representative of the general at-risk population.

Respectively, prodromal research is in a relatively nascent state. While the samples are currently small, important conclusions may be drawn from this growing body of research, particularly as prospective longitudinal designs offer a new prespectie21. For example, prodromal studies with comparative samples size have been important in elucidating our understanding of other potential biomarkers associated with risk for conversion such a prenatal exposure to virus22 and hyperkinetic movements23. Nonetheless, this present data should be interpreted as a pioneer study. Results from the present study suggest OCs as a useful candidate marker for identifying individuals who may stand to benefit most from preventive intervention; it is our hope that these preliminary findings will encourage and influence future research in this area.

Acknowledgments

V.A.M.'s time was supported by Grant MH14584-33. This work was also supported by Grant MH52857 from the National Institute of Mental Health (to T.D.C.). Additional support was provided by Center for Computational Biology Grant U54 RR021813 and P41 Resource Grant RR013642 from the National Center for Research Resources. Funding was also provided by a gift to the UCLA Foundation from the Staglin Music Festival for Mental Health.

Author Mittal conducted statistical analyses and the literature search and wrote the first draft of the present manuscript. Author Willhite aided in the writing of the manuscript and in developing the theoretical conceptualizations. Author Niendam aided in the revision of the manuscript and in data collection. Author Bearden helped to design the study, write the protocol, co-direct data collection, and edit the manuscript. Author Daley provided psychiatric consultation throughout the study, co-directed data collection, and edited the manuscript. Author Ellman aided in editing as well as providing conceptualization and theory used to integrate findings. Finally, Author Cannon helped to design the study, write the protocol, obtain primary grant funding, direct data collection, and edit the manuscript.

Footnotes

All authors contributed to and have approved the final manuscript.

References

  • 1.Walker EF, Diforio D. Schizophrenia: A neural diathesis-stress model. Psychol Rev. 1997;104(4):667–685. doi: 10.1037/0033-295x.104.4.667. [DOI] [PubMed] [Google Scholar]
  • 2.Mittal VA, Dhruv S, Tessner KD, Walder DJ, Walker EF. The relations among putative bio risk markers in Schizotypal Adolescents: minor physical anomalies, movement abnormalities and salivary cortisol. Biol Psychiatry. 2007;61(10):1179–1186. doi: 10.1016/j.biopsych.2006.08.043. [DOI] [PubMed] [Google Scholar]
  • 3.Rosso IM, Cannon TD, Huttunen T, Huttunen MO, Lonnqvist J, Gasperoni TL. Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort. Am J Psychiatry. 2000;157(5):801–807. doi: 10.1176/appi.ajp.157.5.801. [DOI] [PubMed] [Google Scholar]
  • 4.Verdoux H, Geddes JR, Takei N, et al. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry. 1997;154(9):1220–1227. doi: 10.1176/ajp.154.9.1220. [DOI] [PubMed] [Google Scholar]
  • 5.Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multi-site longitudinal study in North America. Arch Gen Psychiatry. 2008;65(1):28–37. doi: 10.1001/archgenpsychiatry.2007.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull. 2006;32:116–178. doi: 10.1093/schbul/sbj007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Meyer SE, Bearden CE, Lux SR, et al. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adolesc Psychopharmacol. 2005;15(3):434–451. doi: 10.1089/cap.2005.15.434. [DOI] [PubMed] [Google Scholar]
  • 8.Miller T, McGlashan TH, Rosen JL. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured Interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863–865. doi: 10.1176/appi.ajp.159.5.863. [DOI] [PubMed] [Google Scholar]
  • 9.First M, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID-I), Patient Edition. Washington DC: American Psychiatric Press; 1995. [Google Scholar]
  • 10.Kaufman J, Birmaher B, Brent D, Rao U, Ryan N. Kiddie-SADS Present and Lifetime Version (K-SADS-PL) Pittsburgh, PA: University of Pittsburgh, Department of Psychiatry; 1996. [Google Scholar]
  • 11.Riley B, Kendler KS. Molecular genetic studies of schizophrenia. Eur J Hum Gen. 2006;14(6):669–680. doi: 10.1038/sj.ejhg.5201571. [DOI] [PubMed] [Google Scholar]
  • 12.Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am Journal Psychiatry. 2002;159(4):539–545. doi: 10.1176/appi.ajp.159.4.539. [DOI] [PubMed] [Google Scholar]
  • 13.Lewis SW, Owen MJ, Murray RM. Obstetric complications and schizophrenia: methodology and mechanisms. In: Schultz SC, Taminga CA, editors. Schizophrenia: A Scientific Focus. Oxford, UK: Oxford University Press; 1989. pp. 56–68. [Google Scholar]
  • 14.Van Erp TG, Saleh PA, Rosso IM, et al. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry. 2002;159(9):1514–1520. doi: 10.1176/appi.ajp.159.9.1514. [DOI] [PubMed] [Google Scholar]
  • 15.Cannon TD, van Erp TG, Rosso IM, et al. Fetal hypoxia and structural brain a abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry. 2002;59(1):35–41. doi: 10.1001/archpsyc.59.1.35. [DOI] [PubMed] [Google Scholar]
  • 16.Mittal VA, Ellman LM, Cannon TD. Gene-environment interaction and covariation in schizophrenia: The role of obstetric complications. Schizophr Bull. 2008;34:1083–1094. doi: 10.1093/schbul/sbn080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yun Y, Phillips LJ, Cotton S, Yung AR, Francey SM, Yuen HP, McGorry PD. Obstetric complications and transition to psychosis in an ‘ultra’ high risk sample. Aust New Zeal J Psychiatry. 2005;255(39):460–466. doi: 10.1080/j.1440-1614.2005.01604.x. [DOI] [PubMed] [Google Scholar]
  • 18.Balloon JS, Dean KA, Cadenhead KS. Obstetrical complications in people at risk for developing schizophrenia. Schizophr Res. 2008;98:307–311. doi: 10.1016/j.schres.2007.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Clarke MC, Harlery M, Cannon M. The role of obstetric events in schizophrenia. Schizophr Bull. 2006;32(1):3–8. doi: 10.1093/schbul/sbj028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.McIntosh AM, Holmes S, Gleeson S, Burns JD, Hodges AK. Maternal recall bias, obstetric history and schizophrenia. Br J Psychiatry. 2002;181:520–525. doi: 10.1192/bjp.181.6.520. [DOI] [PubMed] [Google Scholar]
  • 21.Mittal VA, Neumann C, Saczawa M, Walker EF. The longitudinal progression of movement abnormalities and psychotic symptoms in adolescents at high-risk for psychosis. Arch Gen Psychiatry. 2008;65(2):165–170. doi: 10.1001/archgenpsychiatry.2007.23. [DOI] [PubMed] [Google Scholar]
  • 22.Mittal VA, Saczawa M, Walder DJ, Willhite R, Walker EF. Prenatal viral teratogen exposure and conversion among adolescents at high-risk for psychosis. Schizophrenia Res. 2008;99:375–376. doi: 10.1016/j.schres.2007.11.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mittal VA, Walker EF. Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents. Journal of Abnormal Psychol. 2007;116(4):796–803. doi: 10.1037/0021-843X.116.4.796. [DOI] [PubMed] [Google Scholar]

RESOURCES